Fingerprint
Dive into the research topics of 'Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically